X0609 4/A 2026-01-23 2026-01-26 0001091596 Nuo Therapeutics, Inc. AURX 0001674752 Pittman Scott M. false C/O NUO THERAPEUTICS, INC. 8285 EL RIO, SUITE190 HOUSTON TX 77054 1 1 0 Initial Warrant (right to buy) 1.50 2026-01-23 4 A 0 30050 1.50 A 2026-01-23 2031-01-23 Common Stock 30050 30050 D Second Warrant (right to buy) 1.50 2026-01-23 4 A 0 36750 1.50 A 2026-09-30 2031-01-23 Common Stock 36750 0 D Prepayment Warrant (right to buy) 1.50 2026-01-23 4 A 0 7516 1.50 A 2026-01-23 2031-01-23 Common Stock 7516 0 D This Form 4 amendment corrects the name of warrant issued in the form of an integrated Initial Warrant, which represents Commitment Initial, Origination Initial, and Capital Initial Warrants immediately exercisable for an aggregate of 30,050 shares of Common Stock. This Form 4 amendment corrects the name of warrant issued in the form of an integrated Second Warrant, which represents Origination Second Capital Second Warrants. Will vest (if at all) on September 30, 2026 provided a Second Funding occurs in accordance with the Loan and Security Agreement dated January 21, 2026 among the Issuer, the Reporting Person, and other parties thereto (the "Loan Agreement"). Represents maximum number of shares issuable (if at all) in the event of a Prepayment in accordance with the Loan Agreement. Will vest (if at all) upon the occurrence of a Prepayment, but no later than December 31, 2028, in accordance with the Loan Agreement. /s/ David Jorden, attorney-in-fact 2026-06-02